| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0005 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.0006 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |